Literature DB >> 11007821

Glomerular function and morphology in puromycin aminonucleoside nephropathy in rats.

E K Löwenborg1, G Jaremko, U B Berg.   

Abstract

BACKGROUND: The most characteristic manifestation of minimal-change nephropathy is podocyte cell process broadening. In a previous study in children from our unit, we found an inverse correlation between foot process width, glomerular filtration rate (GFR), and filtration fraction. The aim of the present study was to determine whether this relationship also existed in the puromycin aminonucleoside (PAN) experimental model.
METHODS: Sixteen Munich-Wistar-Frömter male rats initially weighing median 247 g (range 171-286) were used. Four rats served as controls. The other 12 rats were divided into three groups receiving daily subcutaneous injections of 1, 1.67, and 2.5 mg PAN/100 g body weight respectively, for 6 days. GFR was determined by clearance of inulin and the fractional urine albumin excretion was measured. Standard stereological methods were used to estimate the glomerular volume, the mean foot process width and the length density of slit pores.
RESULTS: GFR decreased with increasing PAN doses. The glomerular volume was increased in the group receiving the lowest PAN dose, while it was decreased in the group with the highest PAN dose, compared with controls. The fractional albumin excretion and the foot process width increased and the total slit pore length decreased with increasing doses of PAN. GFR correlated directly with the glomerular volume as did the foot process width with the fractional albumin excretion. The foot process width correlated inversely with the glomerular volume as did the glomerular volume with the fractional albumin excretion, and GFR with foot process width.
CONCLUSIONS: The decreased GFR found in the nephrotic rats was inversely related to foot process width and directly related to glomerular volume, confirming our previous results in children in an early stage of the nephrotic syndrome.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11007821     DOI: 10.1093/ndt/15.10.1547

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  11 in total

1.  Why the kidney glomerulus does not clog: a gel permeation/diffusion hypothesis of renal function.

Authors:  Oliver Smithies
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-24       Impact factor: 11.205

2.  Co-localization of nephrin, podocin, and the actin cytoskeleton: evidence for a role in podocyte foot process formation.

Authors:  Moin A Saleem; Lan Ni; Ian Witherden; Karl Tryggvason; Vesa Ruotsalainen; Peter Mundel; Peter W Mathieson
Journal:  Am J Pathol       Date:  2002-10       Impact factor: 4.307

3.  Motor protein Myo1c is a podocyte protein that facilitates the transport of slit diaphragm protein Neph1 to the podocyte membrane.

Authors:  E Arif; M C Wagner; D B Johnstone; H N Wong; B George; P A Pruthi; M J Lazzara; D Nihalani
Journal:  Mol Cell Biol       Date:  2011-03-14       Impact factor: 4.272

4.  Unsupervised labeling of glomerular boundaries using Gabor filters and statistical testing in renal histology.

Authors:  Brandon Ginley; John E Tomaszewski; Rabi Yacoub; Feng Chen; Pinaki Sarder
Journal:  J Med Imaging (Bellingham)       Date:  2017-02-28

5.  Protective effects of PPARγ agonist in acute nephrotic syndrome.

Authors:  Yiqin Zuo; Hai-Chun Yang; Sebastian A Potthoff; Behzad Najafian; Valentina Kon; Li-Jun Ma; Agnes B Fogo
Journal:  Nephrol Dial Transplant       Date:  2011-05-12       Impact factor: 5.992

6.  Ischemic injury to kidney induces glomerular podocyte effacement and dissociation of slit diaphragm proteins Neph1 and ZO-1.

Authors:  Mark C Wagner; George Rhodes; Exing Wang; Vikas Pruthi; Ehtesham Arif; Moin A Saleem; Sarah E Wean; Puneet Garg; Rakesh Verma; Lawrence B Holzman; Vince Gattone; Bruce A Molitoris; Deepak Nihalani
Journal:  J Biol Chem       Date:  2008-10-14       Impact factor: 5.157

7.  Renoprotective effect of topiroxostat via antioxidant activity in puromycin aminonucleoside nephrosis rats.

Authors:  Yosuke Kawamorita; Takeshi Shiraishi; Yoshifuru Tamura; Takanori Kumagai; Shigeru Shibata; Yoshihide Fujigaki; Makoto Hosoyamada; Takahiko Nakagawa; Shunya Uchida
Journal:  Physiol Rep       Date:  2017-08

8.  In vivo mutagenicity and tumor-promoting activity of 1,3-dichloro-2-propanol in the liver and kidneys of gpt delta rats.

Authors:  Kohei Matsushita; Shinji Takasu; Yuji Ishii; Takeshi Toyoda; Takanori Yamada; Tomomi Morikawa; Kumiko Ogawa
Journal:  Arch Toxicol       Date:  2021-07-16       Impact factor: 5.153

9.  Kidney-derived c-kit+ progenitor/stem cells contribute to podocyte recovery in a model of acute proteinuria.

Authors:  Erika B Rangel; Samirah A Gomes; Rosemeire Kanashiro-Takeuchi; Russell G Saltzman; Changli Wei; Phillip Ruiz; Jochen Reiser; Joshua M Hare
Journal:  Sci Rep       Date:  2018-10-03       Impact factor: 4.379

10.  Puromycin aminonucleoside triggers apoptosis in podocytes by inducing endoplasmic reticulum stress.

Authors:  Seo-Yun Min; Dong-Soo Ha; Tae-Sun Ha
Journal:  Kidney Res Clin Pract       Date:  2018-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.